camiseta barcelona 2013

camiseta barcelona 2013,
Ranbaxy Inc. the India’s largest pharmaceutical company and one of the world’s biggest generic-drug makers is investigated by US Justice Department and Food and Drug Administration (FDA) to know whether it manufactured substandard generic drugs. Allegations are made that it manufactured weak or adulterated HIV drugs, which were given to thousands of AIDS patients in Africa.
US government paid Ranbaxy millions of dollars under the president’s emergency plan for AIDS relief to provide low-cost antiretroviral drugs for the AIDS patients in Africa. Investigators at the Justice Department and Food and Drug Administration made allegations that some of the drugs equipación barcelona manufactured by Ranbaxy were poorly made, unstable, or impotent. Ranbaxy also changed the documents to cover-up the substandard products were found by the court filings and lawyers close to the investigation.
Ranbaxy issued a statement acknowledging the probe from its Gurgoan, India, headquarters because of which its shares fell more than 10% on Monday in London trading. As the details of the inquiry were not disclosed previously it raised the difficult questions for the company of its recent $4.6 billion sale of camiseta barcelona 2013 a majority stake to Daiichi Sankyo Co. of Japan, and a separate pact segunda camiseta barcelona with Pfizer Inc. reached in June to license a generic version of Pfizer’s blockbuster cholesterol drug Lipitor.